By Dr Brendan Clifford

Conference Presentations

Acheson L; Ezard N; Fletcher K; Clifford B; Steele M; Moses M; Siefried K, 2024, 'A heuristic for evaluating methamphetamine withdrawal treatment programs', presented at Australasian Professional Society on Alcohol and other Drugs (APSAD) Scientific Conference 2024, Canberra, Australia, 30 October 2024 - 02 November 2024, http://dx.doi.org/10.1111/dar.13943

Broadbent E; Siefried K; Ezard N; MacDonald H; Gobeil J; Clifford B, 2024, 'Implementing a national Prompt Response Network to improve health-led decision making and processes for emerging drugs', presented at Australasian Professional Society on Alcohol and other Drugs (APSAD) Scientific Conference 2024, Canberra, Australia, 30 October 2024 - 02 November 2024, http://dx.doi.org/10.1111/dar.13943

Clifford B, 2024, 'Emerging drugs of concern - Prompt Response Network update', presented at 2024 NDARC Annual Research Symposium, Wesley Conference Centre, Sydney NSW, 20 September 2024, https://www.youtube.com/watch?v=vxBO7_cTwPU&t=3141s

Siefried K; Clifford B; Acheson L; Ezard N, 2023, 'Innovations beyond BC: Lisdexamfetamine for the treatment of methamphetamine use disorder and withdrawal', presented at The 5th Annual BC Substance Use Conference, Vancouver, Canada, 20 April 2023 - 23 April 2023

Hill P; Clifford B; Brown J; Dessauer P; Oh G; Lyons T; Herbert A; McKinnon G; Lamb M; Crawford S; Mason C; Siefried K; Ezard N, 2023, 'Strength in solidarity: Bringing together diverse local stakeholders to disseminate public drug information (presented on behalf of the Prompt Response Network)', presented at Harm Reduction International, Melbourne, Australia, 16 April 2023 - 19 April 2023, https://hr23.hri.global/programme/

Bascombe F; Siefried K; Clifford B; Middleton P; Liu Z; Wilson J; Steele M; Kay-Lambkin F; Ezard N, 2022, 'Feasibility and efficacy of the S-Check App to change help seeking behaviour of people who use methamphetamine', presented at Lisbon Addictions, Lisbon, Portugal, 23 November 2022 - 25 November 2022

Ezard N; Clifford B; Siefried K; Acheson L, 2022, 'Safety and tolerability of lisdexamfetamine for  methamphetamine dependence and withdrawal, early experience from Australia: The LiMA Trial and OLAM pilot', presented at Annual Meeting Conference of the Norwegian Association for Addiction Medicine, Bergen, Norway, 02 November 2022

Back to profile page